Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.86 EUR
Change Today -0.04 / -1.03%
Volume 0.0
E1S On Other Exchanges
Symbol
Exchange
Berlin
Xetra
As of 2:25 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

luz saude sa (E1S) Snapshot

Open
€3.78
Previous Close
€3.90
Day High
€3.90
Day Low
€3.78
52 Week High
10/8/14 - €4.95
52 Week Low
12/10/14 - €3.04
Market Cap
368.8M
Average Volume 10 Days
5.0
EPS TTM
--
Shares Outstanding
95.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LUZ SAUDE SA (E1S)

Related News

No related news articles were found.

luz saude sa (E1S) Related Businessweek News

No Related Businessweek News Found

luz saude sa (E1S) Details

Luz Saúde, S.A., together with its subsidiaries, operates a network of healthcare facilities in Portugal. The company operates through three segments: Private Healthcare, Public Healthcare, and Other Activities. Its hospitals offer acute care services, such as surgery, inpatient treatment, and diagnostic procedures, as well as undertake activities to promote health and prevent disease, such as check-ups and other preventive healthcare. The company’s outpatient clinics provide non-acute primary care services, including external consultation for medical and surgical specialties, diagnostic and therapeutic procedures for imaging and laboratory testing, as well as medical assistance and various surgical procedures. Its residential care facility offers rehabilitation, medical or post-operative convalescence, neurostimulation, and general support for patients with dementia disease, as well as palliative care and geriatric care in a day centre or inpatient setting. In addition, the company operates senior residences that provide housing, leisure, and healthcare services; and radiotherapy unit. It operates 18 healthcare units, including 8 private hospitals, 1 public hospital, 7 private outpatient clinics, and 2 senior residences. The company was formerly known as Espírito Santo Saúde-SGPS, S.A. and changed its name to Luz Saúde, S.A. in February 2015. Luz Saúde, S.A. was founded in 2000 and is headquartered in Lisbon, Portugal. As of October 14, 2014, Luz Saúde, S.A. operates as a subsidiary of Fidelidade-Companhia de Seguros, S.A.

Founded in 2000

luz saude sa (E1S) Top Compensated Officers

Vice President of the Board, Chief Executive ...
Total Annual Compensation: €590.6K
Chief Financial Officer, Director and Member ...
Total Annual Compensation: €413.7K
Chief Operations Officer, Director and Member...
Total Annual Compensation: €413.8K
President of Clinical Management Board
Total Annual Compensation: €9.2K
Chief Information & Technology Officer, Direc...
Total Annual Compensation: €413.5K
Compensation as of Fiscal Year 2014.

luz saude sa (E1S) Key Developments

Luz Saúde, S.A., Annual General Meeting, May 21, 2015

Luz Saúde, S.A., Annual General Meeting, May 21, 2015.

Espírito Santo Saúde SGPS, SA. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Espírito Santo Saúde SGPS, SA. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported operating revenues of EUR 96.7 million compared with EUR 90.5 million a year ago. EBITDA was EUR 15.5 million compared with EUR 15.1 million a year ago. EBIT was EUR 9.0 million compared with EUR 8.2 million a year ago. Net income was EUR 5.5 million against EUR 3.1 million a year ago. Income before taxes was EUR 7.3 million against EUR 5.7 million a year ago. For the first half, the company reported operating revenues of EUR 297.8 million compared with EUR 279.5 million a year ago. EBITDA was EUR 43.8 million compared with EUR 43.1 million a year ago. EBIT was EUR 23.6 million compared with EUR 22.1 million a year ago. Net income was EUR 14.2 million against EUR 9.1 million a year ago. Net income attributable to shareholders was EUR 14.2 million or EUR 0.151 per share against EUR 9.0 million or EUR 0.102 per share a year ago. Income before taxes was EUR 18.1 million against EUR 14.0 million a year ago. Cash flow from operations was EUR 34.4 million against EUR 30.1 million a year ago.

Espírito Santo Saúde SGPS, SA. Reports Unaudited Consolidated Earnings Results for the Second Quarter and First Half ended June 2014

Espírito Santo Saúde SGPS, SA. reported unaudited consolidated earnings results for the second quarter and first half ended June 2014. For the second quarter, the company reported revenue from sales and services provided of EUR 98.9 million compared with EUR 94.3 million a year ago. Total income and earnings EUR 99.6 million compared with EUR 95.6 million a year ago. Income before taxes was EUR 4.5 million compared with EUR 5.0 million a year ago. Net income attributable to equity shareholders was EUR 4.1 million compared with EUR 3.7 million a year ago, driven by the operational results and by the financial results improvement, as a result of outstanding debt reduction and spreads improvement. Earnings per share were EUR 0.043 compared with EUR 0.041 a year ago. EBITDA was EUR 12.9 million compared with EUR 14.6 million a year ago. EBIT was EUR 6.3 million compared with EUR 7.6 million a year ago. For the first half, the company reported revenue from sales and services provided of EUR 200.2 million compared with EUR 187.6 million a year ago. Total income and earnings was EUR 201.4 million compared with EUR 189.3 million a year ago. Income before taxes was EUR 10.8 million compared with EUR 8.3 million a year ago. Net income attributable to equity shareholders was 8.7 million compared with EUR 6.0 million a year ago. Earnings per share were EUR 0.093 compared with EUR 0.068 a year ago. EBITDA was EUR 28.3 million compared with EUR 28.0 million a year ago. EBIT was EUR 14.6 million compared with EUR 13.9 million a year ago. Cash flow from operations was EUR 22.3 million compared with EUR 20.1 million a year ago. Capex was EUR 7.5 million compared with EUR 5.1 million a year ago. Net debt at June 2014 was EUR 184.1 million. Total income and earnings EUR 201.4 million compared with EUR 189.3 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
E1S:GR €3.86 EUR -0.04

E1S Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for E1S.
View Industry Companies
 

Industry Analysis

E1S

Industry Average

Valuation E1S Industry Range
Price/Earnings 22.2x
Price/Sales 1.0x
Price/Book 2.2x
Price/Cash Flow 9.4x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LUZ SAUDE SA, please visit www.essaude.pt. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.